|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | (2013.01) |
| A61P 35/00 | (2006.01) | ||
| C07K 16/28 | (2006.01) | ||
| C07K 16/28 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| C07K 16/2818 | (2013.01) | ||
| C07K2317/22 | (2013.01) | ||
| C07K2317/60 | (2013.01) | ||
| A61P 1/04 | (2018.01) | ||
| A61P 1/16 | (2018.01) | ||
| A61P 11/00 | (2018.01) | ||
| A61P 11/02 | (2018.01) | ||
| A61P 13/10 | (2018.01) | ||
| A61P 13/12 | (2018.01) | ||
| A61P 15/00 | (2018.01) | ||
| A61P 17/00 | (2018.01) | ||
| A61P 19/08 | (2018.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 31/00 | (2018.01) | ||
| A61P 31/04 | (2018.01) | ||
| A61P 31/12 | (2018.01) | ||
| A61P 31/16 | (2018.01) | ||
| A61P 31/18 | (2018.01) | ||
| A61P 31/22 | (2018.01) | ||
| A61P 33/02 | (2018.01) | ||
| A61P 33/06 | (2018.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61P 7/00 | (2018.01) |
| (11) | Patento numeris | 3459597 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17798775.7 |
| Europos patento paraiškos padavimo data | 2017-05-19 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-03-27 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-08-31 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2017/085038 |
| Data | 2017-05-19 |
| (87) | Numeris | WO 2017/198212 |
| Data | 2017-11-23 |
| (30) | Numeris | Data | Šalis |
| 201610332590 | 2016-05-19 | CN |
| (72) |
XU, Ting , CN
WANG, Xiaoxiao , CN
LI, Jie , CN
WU, Haiyan , CN
GAO, Li , CN
CHU, Qian , CN
BAI, Yu , CN
|
| (73) |
Suzhou Alphamab Co., Ltd ,
Building C23 BioBay
Xinghu Street
No. 218 Suzhou, Jiangsu 215125,
CN
Zhang, Xitian , 666-2 Dapu Road Room 2001 Huangpu District, Shanghai 200023, CN Zhang, Xin , Building 6, Room 1701, No.800 Dongan Road, Xuhui District,, Shanghai 200032, CN |
| (54) | SINGLE DOMAIN ANTIBODY FOR CTLA4 AND DERIVED PROTEIN THEREOF |
| SINGLE DOMAIN ANTIBODY FOR CTLA4 AND DERIVED PROTEIN THEREOF |